
Publications of M. A. Oberli
All genres
Journal Article (7)
1.
Journal Article
49 (64), pp. 7159 - 7161 (2013)
Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine. Chemical Communications 2.
Journal Article
135 (26), pp. 9713 - 9722 (2013)
Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope. Journal of the American Chemical Society 3.
Journal Article
18 (5), pp. 580 - 588 (2011)
A possible oligosaccharide-conjugate vaccine candidate for Clostridium difficile is antigenic and immunogenic. Chemistry & Biology 4.
Journal Article
193 (14), pp. 3506 - 3511 (2011)
Identification of an African Bacillus anthracis lineage that lacks expression of the spore surface-associated anthrose-containing oligosaccharide. Journal of Bacteriology 5.
Journal Article
11 (11), pp. 1563 - 1573 (2010)
Determination of carbohydrate-binding preferences of human galectins with carbohydrate microarrays. ChemBioChem: A European Journal of Chemical Biology 6.
Journal Article
132 (30), pp. 10239 - 10241 (2010)
Molecular analysis of carbohydrate-antibody interactions: case study using a Bacillus anthracis tetrasaccharide. Journal of the American Chemical Society 7.
Journal Article
26 (22), pp. 17143 - 17155 (2010)
Surface characterization of carbohydrate microarrays. Langmuir Book Chapter (1)
8.
Book Chapter
Synthetic oigosaccharide bacterial antigens to produce monoclonal antibodies for diagnosis and treatment of disease using Bacillus anthracis as a case study. In: Anticarbohydrate antibodies: from molecular basis to clinical application, pp. 37 - 54 (Eds. Kosma, P.; Müller-Loennies, S.). Springer-Verlag, Wien (2012)
Patent (1)
9.
Patent
Oligosaccharides and oligosaccharide-protein conjugates derived from clostridium difficile polysaccharide PS-II, methods of synthesis and uses thereof, in particular as a vaccine. EP2683401 (2012)